
High Court Clarifies the Principles for Preliminary Discovery – Weight of Expert Evidence
The High Court has rejected granting special leave to Samsung Bioepis (‘SB’) to challenge the decision of the Full Federal Court in Pfizer Ireland Pharmaceuticals




